| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/20/2004 | EP1467616A2 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 10/20/2004 | EP1467615A1 Methods to engineer mammalian-type carbohydrate structures |
| 10/20/2004 | EP1373292A4 Cell cycle nucleic acids, polypeptides and uses thereof |
| 10/20/2004 | EP1251730A4 Preparation and use of polymers crosslinked with tyrosine-containing peptides |
| 10/20/2004 | EP1226259B1 Isolation and characterization of a fiber-specific actin promoter from cotton |
| 10/20/2004 | EP1198477B1 Prolactin-releasing peptide and use in treating pain |
| 10/20/2004 | EP1179179B1 Use of an antibody to detect basophiles and/or mast cells |
| 10/20/2004 | EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 10/20/2004 | EP1154790B1 Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs |
| 10/20/2004 | EP1151008B1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 10/20/2004 | EP1105156B1 Non-virulent porphyromonas gingivalis mutant |
| 10/20/2004 | EP1104772B1 Anti-l7/l12 antibody for detecting bacteria |
| 10/20/2004 | EP1032592A4 Antimicrobial peptides |
| 10/20/2004 | EP0959895B1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins |
| 10/20/2004 | EP0956355B1 Method for immortalizing cells |
| 10/20/2004 | EP0954332B1 Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases |
| 10/20/2004 | EP0935604A4 Magnetically activated cell sorting for production of proteins |
| 10/20/2004 | EP0886644B1 Long wavelength engineered fluorescent proteins |
| 10/20/2004 | EP0821733B1 Genetic markers for breast and ovarian cancer |
| 10/20/2004 | EP0734451B1 ENTEROTOXINS OF SHIGELLA FLEXNERI 2a |
| 10/20/2004 | EP0722461B1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 10/20/2004 | EP0668906B1 Method for producing polypeptide via bacterial fermentation |
| 10/20/2004 | EP0658113B1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 10/20/2004 | CN1538973A Factor VIII separation |
| 10/20/2004 | CN1538854A Mutant forms of cholera holotoxin as adjuvant |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1538852A Mixtures of growth horomone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof and methods of making same |
| 10/20/2004 | CN1538851A Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and method of making same |
| 10/20/2004 | CN1538850A BMP Binding proteins for use in bone or cartilage regenearation |
| 10/20/2004 | CN1538849A Use of long PENTRAXIN PTX 3 for treating female infertility |
| 10/20/2004 | CN1538809A Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, used thereof and methods of making same |
| 10/20/2004 | CN1538176A Antagonism agent and ultra-antagonism agent for hormone screened by membrane molecule gp 130 active cell physiological regulation mechanism |
| 10/20/2004 | CN1537865A Method of extracting lactoalbumin, nucleic acid oligosaccharide, isoflavone, saponin from yellow waste water generated by producing soybean |
| 10/20/2004 | CN1537633A Protein having antitumor function, and high performance expression in vitro |
| 10/20/2004 | CN1171997C Modified TLE-2-receptor ligands |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171995C Assay for the diagnosis of schizophrenia based on a new peptide |
| 10/20/2004 | CN1171902C Antisercretory factor petides regulating pathological permeability changes |
| 10/20/2004 | CN1171901C New interferon-like protein and its code sequence and use |
| 10/20/2004 | CN1171900C Novel, ubiquitous potassium-channel proteins and genes for the same |
| 10/20/2004 | CN1171899C Structure and usage of plasminogen activator (TPA) mutant |
| 10/20/2004 | CN1171637C Vaccine against nepatitis B Birus and human papilloma virus |
| 10/19/2004 | US6806400 By supplying a virally encoded booster sequence comprising the 5' proximal region of the potyvirus genome or by supplying other sequences encoding suppressors of gene silencing alone or in combination |
| 10/19/2004 | US6806360 Nucleic acids encoding human tissue factor inhibitor |
| 10/19/2004 | US6806359 Hormone receptor compositions and methods |
| 10/19/2004 | US6806358 Comprises a fragment of the drosophilia short gastrulation (sog) gene which includes the cysteine-rich repeat of sog; for use in therapeutics and diagnostics |
| 10/19/2004 | US6806355 Purification of preferential globulin; obtain sample containing globulin, expose to ion exchange column, filter and recover globulin |
| 10/19/2004 | US6806352 Nucleotide sequences coding membrane proteins/pro-polypeptides; anticarcinogenic/antitumor agents |
| 10/19/2004 | US6806351 Nucleotide sequences coding proteins for use in the diagnosis and treatment of hematopoietic or immune disorders |
| 10/19/2004 | US6806255 Compounds and methods for modulating adhesion molecule function |
| 10/19/2004 | US6806254 An isolated polynucleotide containing a nucleotide sequence with a specific sequence, translated protein coding protion, mature protein coding protion, extracellular portion or the active domain, codes a polypeptide |
| 10/19/2004 | US6806253 Therapeutic and preventive anti-bacterial vaccine complex |
| 10/19/2004 | US6806086 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 10/19/2004 | US6806084 Comprises dna/lipid carrier complexes for transfection; for modulating the genotype and phenotype into two or more tissues following systemic administration; for gene therapy |
| 10/19/2004 | US6806083 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of atherosclerosis, heart defects, high blood pressure and stroke |
| 10/19/2004 | US6806082 Nucleotide sequence coding controlling polypeptide for use in the prevention of fungal infections |
| 10/19/2004 | US6806077 Method for screening substances with therapeutic action in the treatment of transmissable subacute spongiform encephalopathies |
| 10/19/2004 | US6806074 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 10/19/2004 | US6806065 Rickettsia felis outer membrane protein |
| 10/19/2004 | US6806063 Protein conjugate for use in the treatment of blood disorder |
| 10/19/2004 | US6806062 Fungal transcriptional activator useful in methods for producing polypeptides |
| 10/19/2004 | US6806061 G protein-coupled receptor gene and methods of use therefor |
| 10/19/2004 | US6806055 Preparing viral vaccine; obtain glycoprotein, determine neutralizing epitope, generate vaccine associated with neutralizing epitope |
| 10/19/2004 | US6806054 Non-endogenous, constitutively activated known G protein-coupled receptors |
| 10/19/2004 | US6805882 Therapeutic fractions of sources of HCG |
| 10/19/2004 | US6805870 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament |
| 10/19/2004 | US6805868 Isolated, recombinant polypeptide comprising member selected from specified amino acid sequence and immunogenic fragment of at least 15 contiguous amino acids of that sequence; induces antibody or t-cell mediated immune response when administered |
| 10/19/2004 | US6805867 Bovine rotavirus genes |
| 10/19/2004 | US6805858 Methods for the administration of adenovirus p53 |
| 10/19/2004 | CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 10/19/2004 | CA2282734C Aminopeptidase derived from bacillus licheniformis and process for preparation of natural type proteins |
| 10/19/2004 | CA2059898C Biologically active bacillus thuringiensis isolates and gene encoding a coleopteran-active toxin |
| 10/14/2004 | WO2004088313A1 Nanoparticle for bioaffinity assays |
| 10/14/2004 | WO2004088307A2 Detection method for the expression of recombinant proteins on a cell surface and for the immobilization and purification of cells and proteins |
| 10/14/2004 | WO2004087959A2 Stat-6 gene variants and process of detecting the same |
| 10/14/2004 | WO2004087956A2 Cell lines for the functional expression of nav1.8 |
| 10/14/2004 | WO2004087952A2 Genes regulated by hydrogen peroxide stress |
| 10/14/2004 | WO2004087930A1 Adenovirus replication-competent vectors expressing trail |
| 10/14/2004 | WO2004087924A2 Method for delivery of substances to intracellular microorganisms |
| 10/14/2004 | WO2004087923A1 A NEW STRESS-RESISTANCE TRANSCRIPTION FACTOR (CaPIF1 AND NbPIF1), ITS GENE AND A STRESS-RESISTANCE PLANT TRANSFECTED BY THE GENE |
| 10/14/2004 | WO2004087922A1 Isolation of a novel blue copper protein gene from rice combating salinity stress and possessing agronomic, nutraceutical and cosmaceutical properties |
| 10/14/2004 | WO2004087921A1 Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thererof |
| 10/14/2004 | WO2004087915A1 Seb modification and preventive/remedy for diseases with immune abnormality contianing the same |
| 10/14/2004 | WO2004087912A1 Inhibitor proteins of a protease and use thereof |
| 10/14/2004 | WO2004087910A1 Process for producing plant storage organ with high production of recombinant protein and novel recombinant protein |
| 10/14/2004 | WO2004087904A1 Crystal structure of bovine aptase f1-if1 complex and its use |
| 10/14/2004 | WO2004087900A1 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 10/14/2004 | WO2004087896A2 Hepatocyte differentiation of stem cells |
| 10/14/2004 | WO2004087886A2 Modified adenoviral e1a constructs and methods of use thereof |
| 10/14/2004 | WO2004087883A2 lovE VARIANT REGULATOR MOLECULES |
| 10/14/2004 | WO2004087875A2 Nucleic acid-associated proteins |
| 10/14/2004 | WO2004087874A2 Novel nucleic acids and polypeptides |
| 10/14/2004 | WO2004087866A2 Methods for the identification of inhibitors of lipid transfer protein activity in plants |
| 10/14/2004 | WO2004087767A1 Polypeptide |
| 10/14/2004 | WO2004087766A2 Peptabody for cancer treatment |
| 10/14/2004 | WO2004087760A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
| 10/14/2004 | WO2004087755A2 Plant haemoglobin |
| 10/14/2004 | WO2004087754A1 Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| 10/14/2004 | WO2004087753A1 Mutein of human interferon-beta and its preparation method |
| 10/14/2004 | WO2004087752A2 Spinster-like protein genes, expression products, non-human animal model: uses in human metabolic disorders |